Cargando…
A urinary test procedure for identification of cannabidiol in patients undergoing medical therapy with marijuana
Marijuana is classified by the Drug Enforcement Agency (DEA) as Schedule I, drugs having no accepted medical value. Twenty-three states and the District of Columbia have legalized medical marijuana. This conflict inhibits physicians from prescribing marijuana and the systematic study of marijuana in...
Autores principales: | Wertlake, Paul T, Henson, Michael D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758796/ https://www.ncbi.nlm.nih.gov/pubmed/26929665 http://dx.doi.org/10.2147/JPR.S96856 |
Ejemplares similares
-
Marijuana and Cannabidiol Use Prevalence and Symptom Management Among Patients with Cancer
por: Brasky, Theodore M., et al.
Publicado: (2023) -
Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability
por: Gelmi, Tim J., et al.
Publicado: (2021) -
Marijuana use in children: An update focusing on pediatric tetrahydrocannabinol and cannabidiol use
por: Stoner, Michael J., et al.
Publicado: (2022) -
Role of Marijuana Component (Cannabidiol) in Induction of Regenerative Ability of Stem Cells
por: Miller, Henry P., et al.
Publicado: (2020) -
A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana
por: Grassa, Christopher J., et al.
Publicado: (2021)